AI
| Followers | 141 |
| Posts | 5785 |
| Boards Moderated | 0 |
| Alias Born | 06/09/2020 |
Saturday, February 12, 2022 8:40:52 AM
DD, KnowFear and Bala have created a pure strawman argument.
No, I’ve argued with plenty of links and a video clip on UCLA clinical trial that beyond doubt mention the combo GBM trial with Keytruda and where ATL-DC is DCVax-L.
I’ve never mentioned any lung cancer trial.
Adam Feuerstein tried to sow doubt about DCVax-L being used in this trial and as I documented, didn’t succeed.
But I am glad you agree, that it is DCVax-L under the guise of the generic name ATL-DC, that is being used in the combo trial with Pembrolizumab, Keytruda.
No, I’ve argued with plenty of links and a video clip on UCLA clinical trial that beyond doubt mention the combo GBM trial with Keytruda and where ATL-DC is DCVax-L.
I’ve never mentioned any lung cancer trial.
Adam Feuerstein tried to sow doubt about DCVax-L being used in this trial and as I documented, didn’t succeed.
But I am glad you agree, that it is DCVax-L under the guise of the generic name ATL-DC, that is being used in the combo trial with Pembrolizumab, Keytruda.
A gallimaufry of pulchritudinous terpsichorean burlesque, followed by a veritable floribundum of perfect and plentitudinous prestidigitation and a show of verisimilitudinous, violent, ventriloquial virtuosity.
